Diabetes

The Pharmacy Times® Diabetes resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
A new study has found that patients with heart failure with reduced ejection fraction receiving dapagliflozin decreased their risk of worsening HF or death from cardiovascular events. 
[[thumbnail_alt_text]]
Ocular conditions can lead to serious complications, and sometimes there are no early symptoms.
[[thumbnail_alt_text]]
Metformin hydrochloride extended-release tablets are indicated to for improving glycemic control in patients with type 2 diabetes mellitus, as an adjunct to diet and exercise.
[[thumbnail_alt_text]]
The approval was based on a phase 3 EDITION JUNIOR trial evaluating children and adolescents, aged 6 to 17 years, living with type 1 diabetes.
[[thumbnail_alt_text]]
Clinical data has illustrated how digital interventions can have a substantial material benefit on glycemic control in users with diabetes, with 73 of 162 users in the study reducing their average blood glucose levels to under 140 mg/dL.

 
[[thumbnail_alt_text]]
In honor of World Diabetes Day, AstraZeneca has launched the campaign Diabetes Can Break Your Heart, the national movement aimed to change the trajectory of heart failure in type 2 diabetes.
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
 
[[thumbnail_alt_text]]
What is causing this patient to lose her sense of smell?
[[thumbnail_alt_text]]
Pharmacists can help with product selection and counsel on routine self-monitoring.
[[thumbnail_alt_text]]
Confirming latent autoimmune diabetes in adults and dispensing the correct tube size for triaminoclone.
[[thumbnail_alt_text]]
This intervention fosters connections with patients, identifies treatment goals, and increases adherence.